Zain Rizvi is an expert on drug pricing. He has provided technical assistance to state and national governments, coordinated civil society coalitions, and published on intellectual property, access to medicines and global health. He was a Gruber Fellow at SECTION27, a Johannesburg-based public interest organization. Zain obtained a J.D. from Yale Law School, where he was student director of the Yale Global Health Justice Partnership. He has a bachelor’s degree from McMaster University and has published in medical and legal journals, including The Lancet and the Yale Journal of Law & Technology.
Zain has been published in The Washington Post and The Ottawa Citizen. He has been interviewed on South African national radio.